Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T K Eigentler

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2019
Late recurrence of melanoma after 10 years - Is the course of the disease different from early recurrences?E Sarac, J Wilhelmi, I Thomas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 3, 2018
Time trends in incidence and mortality of cutaneous melanoma in GermanyC Garbe, U Keim, T K Eigentler, et al.
British Journal of Cancer|October 30, 2003
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastasesP Radny, U M Caroli, J Bauer, et al.
British Journal of Cancer|July 12, 2012
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasisB Weide, M Elsässer, P Büttner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2011
Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology GroupA Pflugfelder, A-K Welter, U Leiter, et al.
The British Journal of Dermatology|August 16, 2014
Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trialA Pflugfelder, E Andonov, B Weide, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patientsM V Heppt, M Schlaak, T K Eigentler, et al.
The British Journal of Dermatology|December 16, 2014
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort studyE Livingstone, T K Eigentler, C Windemuth-Kieselbach, et al.
The British Journal of Dermatology|July 15, 2017
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patientsY Teramoto, U Keim, A Gesierich, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2015
Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal studyE Livingstone, C Krajewski, T K Eigentler, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2019
Late recurrence of melanoma after 10 years - Is the course of the disease different from early recurrences?E Sarac, J Wilhelmi, I Thomas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 3, 2018
Time trends in incidence and mortality of cutaneous melanoma in GermanyC Garbe, U Keim, T K Eigentler, et al.
British Journal of Cancer|October 30, 2003
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastasesP Radny, U M Caroli, J Bauer, et al.
British Journal of Cancer|July 12, 2012
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasisB Weide, M Elsässer, P Büttner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2011
Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology GroupA Pflugfelder, A-K Welter, U Leiter, et al.
The British Journal of Dermatology|August 16, 2014
Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trialA Pflugfelder, E Andonov, B Weide, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patientsM V Heppt, M Schlaak, T K Eigentler, et al.
The British Journal of Dermatology|December 16, 2014
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort studyE Livingstone, T K Eigentler, C Windemuth-Kieselbach, et al.
The British Journal of Dermatology|July 15, 2017
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patientsY Teramoto, U Keim, A Gesierich, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2015
Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal studyE Livingstone, C Krajewski, T K Eigentler, et al.
Pageof 3